Publications by authors named "Turkan Aliyeva"
Article Synopsis
- Acromegaly is a rare hormone disorder with significant health issues, and many patients do not respond well to current treatments, prompting this review of the drug pasireotide.
- The study analyzed data from nine studies involving 590 patients, finding that pasireotide achieved biochemical control rates of about 26.5% after one year, alongside improvements in IGF-1 and GH levels.
- However, it also reported common side effects like gastrointestinal issues and hyperglycemia, with a notable increase in new-onset diabetes mellitus at a rate of 23.36% among patients treated with pasireotide.
